Gemcitabine and carboplatin for pretreated metastatic breast cancer: the predictive value of immunohistochemically defined subtypes

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Presenting Features of Breast Cancer Differ by Molecular Subtype

(2009) Lisa Wiechmann et al.   ANNALS OF SURGICAL ONCOLOGY

Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy response

(2009) Jorma J. de Ronde et al.   BREAST CANCER RESEARCH AND TREATMENT

Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancer

(2009) Robin L. Jones et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial

(2009) Judith Hugh et al.   JOURNAL OF CLINICAL ONCOLOGY

Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

(2009) Maggie C. U. Cheang et al.   JNCI-Journal of the National Cancer Institute

Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane

(2009) Alvaro Moreno-Aspitia et al.   MAYO CLINIC PROCEEDINGS

The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer

(2008) Robin L. Jones et al.   BREAST CANCER RESEARCH AND TREATMENT

Phase II Trial of Gemcitabine/Carboplatin (plus Trastuzumab in HER2-Positive Disease) in Patients with Metastatic Breast Cancer

(2008) David Loesch et al.   Clinical Breast Cancer

Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes

(2008) C. Desmedt et al.   CLINICAL CANCER RESEARCH

Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer

(2008) Davide Mauri et al.   JNCI-Journal of the National Cancer Institute

Current Status of Prognostic Profiling in Breast Cancer

(2008) L. Pusztai   ONCOLOGIST